New Revised USP 797 Allergy Compounding

Published: August 7, 2018

iStock 900412110

On July 27 USP released a new proposed revision to the 797 sterile compounding guidelines. In particular, there are substantial changes being implemented to allergy immunotherapy treatment set compounding. In order to be in compliance with the revised USP 797, facilities engaging in the compounding of allergy treatment sets will need to essentially meet all of the testing, qualification, cleaning,...

If you don't have an account, please complete this registration form to read our blog.

If you have an existing client account you can login to view this post.